HomeNewsCrossLife Awarded NIH SBIR Grant for Zika...
CrossLife Awarded NIH SBIR Grant for Zika Point-of-Care Diagnostic
January 2017 |
CrossLife has recently been awarded a Phase 1 Small Business Innovative Research (SBIR) grant from NIH/NIAID for A Rapid Paper Strip Nucleic Acid Test for the Point of Care Detection of Zika virus.